Meet an Unreasonable Venture
Onego Bio
Disrupting the egg business
Onego Bio produces Bioalbumen®, a bioidentical, animal-free egg protein made using precision fermentation with the patented Trichoderma reesei fungus. It offers a sustainable, scalable alternative to traditional egg protein for food manufacturers. Operating from Helsinki and San Diego, the company is pre-revenue but has strong interest from major food producers. Long term, Onego Bio aims to scale production, reduce environmental impact, and disrupt the $300 billion egg market.
Notable Achievements
- Developed a working manufacturing process for non-animal egg protein in just two years.
- Product Bioalbumen® outperforms traditional egg white powder in third-party tests.
- Built a world-class team with broad experience that is not reliant on external parties.
Currently Operating in One Region
Get the Unreasonable Newsletter
Get monthly updates on Onego Bio and all of the other ventures working to solve the world's toughest problems.